Booz Allen Hamilton Holding Corp. (0HOT)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 77.77 |
|---|---|
| 52-week range | 58.50 – 108.93 |
| Return, 1 month / 3 months | +1.1% / +20.7% |
| Return, 1 year / 3 years | −19.7% / −32.2% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 43.0% |
| Worst drawdown (1 year) | -40.1% |
| Average daily value traded | 0.05M USD |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Booz Allen Hamilton Holding Corp. is a consulting firm that provides management and technology services, chiefly to government clients in the United States. Its work spans strategy, analytics, cybersecurity, engineering and mission support, with defense and intelligence agencies among its main customers. The company is headquartered in the United States and also serves civil agencies and some commercial clients. Its people advise on programmes and help organisations plan, build and run complex systems.
Booz Allen Hamilton Holding Corp. trades under the code 0HOT on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Booz Allen Hamilton Holding Corp. (0HOT) trades on the London Exchange in UK. It last closed at USD 77.77 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,430 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.7% and over the last three months it rose 20.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.2% | ||
| From 52-week high | -23.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.7% | ||
| 6-month return | 1.2% | ||
| 12-month return, skipping the last month | -20.6% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.1% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.4% |
|---|---|
| 1 month | +1.1% |
| 3 months | +20.7% |
| 6 months | +1.2% |
| 1 year | −19.7% |
| 3 years | −32.2% |
| 5 years | +6.4% |
Signals
| 50-day / 200-day average | 74.52 / 76.12 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.5900 |
| 9 Jun 2026 | USD 0.5900 |
| 12 Feb 2026 | USD 0.5900 |
| 13 Nov 2025 | USD 0.5500 |
| 13 Aug 2025 | USD 0.5500 |
| 10 Jun 2025 | USD 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.